Does USTEKINUMAB-TTWE Cause Off label use? 8 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Off label use have been filed in association with USTEKINUMAB-TTWE. This represents 9.6% of all adverse event reports for USTEKINUMAB-TTWE.
8
Reports of Off label use with USTEKINUMAB-TTWE
9.6%
of all USTEKINUMAB-TTWE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Off label use From USTEKINUMAB-TTWE?
Of the 8 reports, 3 (37.5%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB-TTWE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB-TTWE Cause?
Crohn's disease (8)
Fatigue (7)
Drug ineffective (6)
Lower respiratory tract infection (6)
Dyspnoea (5)
Headache (5)
Infection (5)
Pruritus (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)